We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-1.18%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.86B
AUM Growth
+$362M
(+8%)
Cap. Flow
+$499M
Cap. Flow
% of AUM
10.26%
Top 10 Holdings %
Top 10 Hldgs %
17.76%
Holding
548
New
154
Increased
98
Reduced
117
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRR
Carbo Ceramics Inc.
CRR
|
+$50.9M |
| 2 |
BHI
Baker Hughes
BHI
|
+$50M |
| 3 |
SHPG
Shire pic
SHPG
|
+$49.7M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$49.3M |
| 5 |
Martin Marietta Materials
MLM
|
+$42.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$72.9M |
| 2 |
VISN
Vistance Networks Inc
VISN
|
+$35.4M |
| 3 |
Timken Company
TKR
|
+$34.1M |
| 4 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$33.8M |
| 5 |
Danaher
DHR
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.84% |
| 2 | Financials | 10.91% |
| 3 | Industrials | 10.79% |
| 4 | Energy | 9.19% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cytokinetics
CYTK
$10.4B
| $109K | ﹤0.01% |
30,881
-3,532
| -10% | -$14.8K |
|
|
CYTO
377
DELISTED
Altamira Therapeutics Ltd
CYTO
| – | – |
0
| – | – |
|
378
CALL
Hartford Financial Services
HIG
$39.3B
| $34K | ﹤0.01% |
+900
| New | +$32.6K |
|
379
American Airlines Group
AAL
$10.6B
| – | – |
-266,031
| Closed | -$10.5M |
|
380
Aecom
ACM
$9.75B
| – | – |
-925,467
| Closed | -$29.8M |
|
381
Accenture
ACN
$108B
| – | – |
-50,000
| Closed | -$4.04M |
|
|
382
PUT
Accenture
ACN
$108B
| – | – |
-90,000
| Closed | -$7.28M |
|
383
Agnico Eagle Mines
AEM
$90.5B
| – | – |
-27,000
| Closed | -$1.03M |
|
384
APA Corp
APA
$13.2B
| – | – |
-100,000
| Closed | -$10.1M |
|
385
Aramark
ARMK
$14.7B
| – | – |
-1,614,994
| Closed | -$30.2M |
|
386
CALL
Baxter International
BAX
$14.2B
| – | – |
-1,879,661
| Closed | -$73.8M |
|
|
387
PUT
Baxter International
BAX
$14.2B
| – | – |
-1,384,984
| Closed | -$54.4M |
|
388
Bausch Health
BHC
$2.34B
| – | – |
-65,047
| Closed | -$8.2M |
|
389
Bristol-Myers Squibb
BMY
$132B
| – | – |
-15,000
| Closed | -$728K |
|
390
Popular Inc
BPOP
$11.1B
| – | – |
-300,000
| Closed | -$10.3M |
|
391
AB InBev
BUD
$165B
| – | – |
-84,746
| Closed | -$9.74M |
|
392
Burlington
BURL
$23.2B
| – | – |
-50,000
| Closed | -$1.59M |
|
393
Coca-Cola Europacific Partners
CCEP
$47.9B
| – | – |
-209,321
| Closed | -$10M |
|
394
Colgate-Palmolive
CL
$74.4B
| – | – |
-96,520
| Closed | -$6.58M |
|
|
CMCM
395
Cheetah Mobile
CMCM
$96.5M
| – | – |
-20,000
| Closed | -$2.12M |
|
396
CALL
CNX Resources
CNX
$5.2B
| – | – |
-150,000
| Closed | -$5.76M |
|
397
PUT
Capri Holdings
CPRI
$1.74B
| – | – |
-175,000
| Closed | -$15.5M |
|
398
Carter's
CRI
$1.47B
| – | – |
-74,196
| Closed | -$5.11M |
|
399
Caesarstone
CSTE
$79.5M
| – | – |
-60,670
| Closed | -$2.98M |
|
400
PUT
Delta Air Lines
DAL
$60.1B
| – | – |
-80,000
| Closed | -$3.1M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q3 2014 Portfolio in Review
As of Q3 2014, Alyeska Investment Group held 548 positions worth $4.86B, up 8% from $4.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $499M of net new capital in Q3 2014, opening 154 new positions and adding to 98 existing holdings. Its largest new stake was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vistance Networks Inc, an estimated $35.4M trimmed.
- Alyeska Investment Group's largest Q3 2014 buy was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.
- Alyeska Investment Group added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $38.9M increase.
- Alyeska Investment Group's biggest Q3 2014 reduction was Vistance Networks Inc, cutting an estimated $35.4M.
- Alyeska Investment Group fully exited Amsurg Corp in Q3 2014, selling an estimated $72.9M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $4.86B portfolio in Q3 2014.
- Alyeska Investment Group opened 154 new positions and closed 170 in Q3 2014.
- Alyeska Investment Group's portfolio value rose 8% quarter-over-quarter to $4.86B.
Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.